Home
About
Pipeline
News & Media
Investors
Contact

ALERT: NEW ARTICLE

IDSA Clinical Infectious Diseases; Emergence and spread of Clostridioides difficile Isolates with Reduced Fidaxomicin Susceptibility in an Acute Care Hospital

Read Publication

Continue

Contacts

Overview
News / Events
Company Info
Financial Info
Stock Data
SEC Filings
Governance
Investor Tools

Company Information
Overview
Presentations
Management Team
Contacts
FAQ

Auditor

Cohn Reznick

Legal Counsel

Mintz Levin

© 2025 Acurx Pharmaceuticals, Inc. All Rights Reserved.

Privacy Policy Disclaimer Sitemap